| Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors M Mecha, A Feliú, PM Iñigo, L Mestre, FJ Carrillo-Salinas, C Guaza Neurobiology of disease 59, 141-150, 2013 | 297 | 2013 |
| Anandamide enhances IL‐10 production in activated microglia by targeting CB2 receptors: Roles of ERK1/2, JNK, and NF‐κB F Correa, M Hernangómez, L Mestre, F Loría, A Spagnolo, F Docagne, ... Glia 58 (2), 135-147, 2010 | 197 | 2010 |
| A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis AG Granja, F Carrillo-Salinas, A Pagani, M Gómez-Cañas, R Negri, ... Journal of Neuroimmune Pharmacology 7, 1002-1016, 2012 | 166 | 2012 |
| Microglia activation states and cannabinoid system: Therapeutic implications M Mecha, FJ Carrillo-Salinas, A Feliú, L Mestre, C Guaza Pharmacology & therapeutics 166, 40-55, 2016 | 161 | 2016 |
| Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis A Cabranes, K Venderova, E de Lago, F Fezza, A Sánchez, L Mestre, ... Neurobiology of disease 20 (2), 207-217, 2005 | 156 | 2005 |
| Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis L Mestre, F Correa, A Arévalo‐Martín, E Molina‐Holgado, M Valenti, ... Journal of neurochemistry 92 (6), 1327-1339, 2005 | 156 | 2005 |
| Activation of cannabinoid CB2 receptor negatively regulates IL‐12p40 production in murine macrophages: role of IL‐10 and ERK1/2 kinase signaling F Correa, L Mestre, F Docagne, C Guaza British journal of pharmacology 145 (4), 441-448, 2005 | 154 | 2005 |
| Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress M Mecha, AS Torrao, L Mestre, FJ Carrillo-Salinas, R Mechoulam, ... Cell death & disease 3 (6), e331-e331, 2012 | 153 | 2012 |
| CD200‐CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation M Hernangómez, L Mestre, FG Correa, F Loría, M Mecha, PM Iñigo, ... Glia 60 (9), 1437-1450, 2012 | 133 | 2012 |
| Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide F Loría, S Petrosino, L Mestre, A Spagnolo, F Correa, M Hernangómez, ... European journal of neuroscience 28 (4), 633-641, 2008 | 132 | 2008 |
| Excitotoxicity in a chronic model of multiple sclerosis: neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation F Docagne, V Muñetón, D Clemente, C Ali, F Loría, F Correa, ... Molecular and Cellular Neuroscience 34 (4), 551-561, 2007 | 129 | 2007 |
| A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules L Mestre, F Docagne, F Correa, F Loría, M Hernangomez, J Borrell, ... Molecular and Cellular Neuroscience 40 (2), 258-266, 2009 | 120 | 2009 |
| Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theiler's virus M Mecha, FJ Carrillo-Salinas, L Mestre, A Feliu, C Guaza Progress in neurobiology 101, 46-64, 2013 | 114 | 2013 |
| A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells F Correa, F Docagne, L Mestre, D Clemente, M Hernangómez, F Loría, ... Biochemical pharmacology 77 (1), 86-100, 2009 | 114 | 2009 |
| An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis F Loría, S Petrosino, M Hernangómez, L Mestre, A Spagnolo, F Correa, ... Neurobiology of disease 37 (1), 166-176, 2010 | 95 | 2010 |
| The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in … F Correa, M Hernangómez-Herrero, L Mestre, F Loría, F Docagne, ... Brain, behavior, and immunity 25 (4), 736-749, 2011 | 78 | 2011 |
| Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system M Hernangómez, F J Carrillo-Salinas, M Mecha, F Correa, L Mestre, ... Current pharmaceutical design 20 (29), 4707-4722, 2014 | 74 | 2014 |
| An easy and fast way to obtain a high number of glial cells from rat cerebral tissue: A beginners approach. M Mecha, PM Iñigo, L Mestre, M Hernangómez, J Borrell, C Guaza | 73 | 2011 |
| Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB 1 receptors L Mestre, PM Iñigo, M Mecha, FG Correa, M Hernangómez-Herrero, ... Journal of Neuroinflammation 8, 1-13, 2011 | 62 | 2011 |
| The role of cannabinoid system on immune modulation: therapeutic implications on CNS inflammation F Correa, L Mestre, E Molina-Holgado, A Arévalo-Martín, F Docagne, ... Mini reviews in medicinal chemistry 5 (7), 671-675, 2005 | 60 | 2005 |
